Global Retinal Biologics Market Growth (Status and Outlook) 2025-2031

September 2025 | 83 pages | ID: G3B09789416EN
LP Information

Abstracts

According to this study, the global Retinal Biologics market size will reach US$ million by 2031.

Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.

United States market for Retinal Biologics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Retinal Biologics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Retinal Biologics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Retinal Biologics players cover Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, AbbVie Inc, Johnson & Johnson Services, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Retinal Biologics Industry Forecast” looks at past sales and reviews total world Retinal Biologics sales in 2024, providing a comprehensive analysis by region and market sector of projected Retinal Biologics sales for 2025 through 2031. With Retinal Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Retinal Biologics industry.

This Insight Report provides a comprehensive analysis of the global Retinal Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Retinal Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Retinal Biologics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Retinal Biologics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Retinal Biologics.

This report presents a comprehensive overview, market shares, and growth opportunities of Retinal Biologics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Macular Degeneration
• Diabetic Retinopathy
• Diabetic Macular Edema
• Uveitis
• Others

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Spark Therapeutics, Inc
• F. Hoffmann-La Roche Ltd
• Regeneron Pharmaceuticals, Inc
• AbbVie Inc
• Johnson & Johnson Services, Inc
• Amgen Inc

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Retinal Biologics Market Size (2020-2031)
  2.1.2 Retinal Biologics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Retinal Biologics by Country/Region (2020, 2024 & 2031)
2.2 Retinal Biologics Segment by Type
  2.2.1 Macular Degeneration
  2.2.2 Diabetic Retinopathy
  2.2.3 Diabetic Macular Edema
  2.2.4 Uveitis
  2.2.5 Others
2.3 Retinal Biologics Market Size by Type
  2.3.1 Retinal Biologics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Retinal Biologics Market Size Market Share by Type (2020-2025)
2.4 Retinal Biologics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Retinal Biologics Market Size by Application
  2.5.1 Retinal Biologics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Retinal Biologics Market Size Market Share by Application (2020-2025)

3 RETINAL BIOLOGICS MARKET SIZE BY PLAYER

3.1 Retinal Biologics Market Size Market Share by Player
  3.1.1 Global Retinal Biologics Revenue by Player (2020-2025)
  3.1.2 Global Retinal Biologics Revenue Market Share by Player (2020-2025)
3.2 Global Retinal Biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RETINAL BIOLOGICS BY REGION

4.1 Retinal Biologics Market Size by Region (2020-2025)
4.2 Global Retinal Biologics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Retinal Biologics Market Size Growth (2020-2025)
4.4 APAC Retinal Biologics Market Size Growth (2020-2025)
4.5 Europe Retinal Biologics Market Size Growth (2020-2025)
4.6 Middle East & Africa Retinal Biologics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Retinal Biologics Market Size by Country (2020-2025)
5.2 Americas Retinal Biologics Market Size by Type (2020-2025)
5.3 Americas Retinal Biologics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Retinal Biologics Market Size by Region (2020-2025)
6.2 APAC Retinal Biologics Market Size by Type (2020-2025)
6.3 APAC Retinal Biologics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Retinal Biologics Market Size by Country (2020-2025)
7.2 Europe Retinal Biologics Market Size by Type (2020-2025)
7.3 Europe Retinal Biologics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Retinal Biologics by Region (2020-2025)
8.2 Middle East & Africa Retinal Biologics Market Size by Type (2020-2025)
8.3 Middle East & Africa Retinal Biologics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RETINAL BIOLOGICS MARKET FORECAST

10.1 Global Retinal Biologics Forecast by Region (2026-2031)
  10.1.1 Global Retinal Biologics Forecast by Region (2026-2031)
  10.1.2 Americas Retinal Biologics Forecast
  10.1.3 APAC Retinal Biologics Forecast
  10.1.4 Europe Retinal Biologics Forecast
  10.1.5 Middle East & Africa Retinal Biologics Forecast
10.2 Americas Retinal Biologics Forecast by Country (2026-2031)
  10.2.1 United States Market Retinal Biologics Forecast
  10.2.2 Canada Market Retinal Biologics Forecast
  10.2.3 Mexico Market Retinal Biologics Forecast
  10.2.4 Brazil Market Retinal Biologics Forecast
10.3 APAC Retinal Biologics Forecast by Region (2026-2031)
  10.3.1 China Retinal Biologics Market Forecast
  10.3.2 Japan Market Retinal Biologics Forecast
  10.3.3 Korea Market Retinal Biologics Forecast
  10.3.4 Southeast Asia Market Retinal Biologics Forecast
  10.3.5 India Market Retinal Biologics Forecast
  10.3.6 Australia Market Retinal Biologics Forecast
10.4 Europe Retinal Biologics Forecast by Country (2026-2031)
  10.4.1 Germany Market Retinal Biologics Forecast
  10.4.2 France Market Retinal Biologics Forecast
  10.4.3 UK Market Retinal Biologics Forecast
  10.4.4 Italy Market Retinal Biologics Forecast
  10.4.5 Russia Market Retinal Biologics Forecast
10.5 Middle East & Africa Retinal Biologics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Retinal Biologics Forecast
  10.5.2 South Africa Market Retinal Biologics Forecast
  10.5.3 Israel Market Retinal Biologics Forecast
  10.5.4 Turkey Market Retinal Biologics Forecast
10.6 Global Retinal Biologics Forecast by Type (2026-2031)
10.7 Global Retinal Biologics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Retinal Biologics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Spark Therapeutics, Inc
  11.1.1 Spark Therapeutics, Inc Company Information
  11.1.2 Spark Therapeutics, Inc Retinal Biologics Product Offered
  11.1.3 Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Spark Therapeutics, Inc Main Business Overview
  11.1.5 Spark Therapeutics, Inc Latest Developments
11.2 F. Hoffmann-La Roche Ltd
  11.2.1 F. Hoffmann-La Roche Ltd Company Information
  11.2.2 F. Hoffmann-La Roche Ltd Retinal Biologics Product Offered
  11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 F. Hoffmann-La Roche Ltd Main Business Overview
  11.2.5 F. Hoffmann-La Roche Ltd Latest Developments
11.3 Regeneron Pharmaceuticals, Inc
  11.3.1 Regeneron Pharmaceuticals, Inc Company Information
  11.3.2 Regeneron Pharmaceuticals, Inc Retinal Biologics Product Offered
  11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Regeneron Pharmaceuticals, Inc Main Business Overview
  11.3.5 Regeneron Pharmaceuticals, Inc Latest Developments
11.4 AbbVie Inc
  11.4.1 AbbVie Inc Company Information
  11.4.2 AbbVie Inc Retinal Biologics Product Offered
  11.4.3 AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AbbVie Inc Main Business Overview
  11.4.5 AbbVie Inc Latest Developments
11.5 Johnson & Johnson Services, Inc
  11.5.1 Johnson & Johnson Services, Inc Company Information
  11.5.2 Johnson & Johnson Services, Inc Retinal Biologics Product Offered
  11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Johnson & Johnson Services, Inc Main Business Overview
  11.5.5 Johnson & Johnson Services, Inc Latest Developments
11.6 Amgen Inc
  11.6.1 Amgen Inc Company Information
  11.6.2 Amgen Inc Retinal Biologics Product Offered
  11.6.3 Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Amgen Inc Main Business Overview
  11.6.5 Amgen Inc Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Retinal Biologics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Retinal Biologics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Macular Degeneration
Table 4. Major Players of Diabetic Retinopathy
Table 5. Major Players of Diabetic Macular Edema
Table 6. Major Players of Uveitis
Table 7. Major Players of Others
Table 8. Retinal Biologics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Retinal Biologics Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Retinal Biologics Market Size Market Share by Type (2020-2025)
Table 11. Retinal Biologics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Retinal Biologics Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Retinal Biologics Market Size Market Share by Application (2020-2025)
Table 14. Global Retinal Biologics Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Retinal Biologics Revenue Market Share by Player (2020-2025)
Table 16. Retinal Biologics Key Players Head office and Products Offered
Table 17. Retinal Biologics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Retinal Biologics Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Retinal Biologics Market Size Market Share by Region (2020-2025)
Table 22. Global Retinal Biologics Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Retinal Biologics Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Retinal Biologics Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Retinal Biologics Market Size Market Share by Country (2020-2025)
Table 26. Americas Retinal Biologics Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Retinal Biologics Market Size Market Share by Type (2020-2025)
Table 28. Americas Retinal Biologics Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Retinal Biologics Market Size Market Share by Application (2020-2025)
Table 30. APAC Retinal Biologics Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Retinal Biologics Market Size Market Share by Region (2020-2025)
Table 32. APAC Retinal Biologics Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Retinal Biologics Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Retinal Biologics Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Retinal Biologics Market Size Market Share by Country (2020-2025)
Table 36. Europe Retinal Biologics Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Retinal Biologics Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Retinal Biologics Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Retinal Biologics Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Retinal Biologics Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Retinal Biologics
Table 42. Key Market Challenges & Risks of Retinal Biologics
Table 43. Key Industry Trends of Retinal Biologics
Table 44. Global Retinal Biologics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Retinal Biologics Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Retinal Biologics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Retinal Biologics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Spark Therapeutics, Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors
Table 49. Spark Therapeutics, Inc Retinal Biologics Product Offered
Table 50. Spark Therapeutics, Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Spark Therapeutics, Inc Main Business
Table 52. Spark Therapeutics, Inc Latest Developments
Table 53. F. Hoffmann-La Roche Ltd Details, Company Type, Retinal Biologics Area Served and Its Competitors
Table 54. F. Hoffmann-La Roche Ltd Retinal Biologics Product Offered
Table 55. F. Hoffmann-La Roche Ltd Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. F. Hoffmann-La Roche Ltd Main Business
Table 57. F. Hoffmann-La Roche Ltd Latest Developments
Table 58. Regeneron Pharmaceuticals, Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors
Table 59. Regeneron Pharmaceuticals, Inc Retinal Biologics Product Offered
Table 60. Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Regeneron Pharmaceuticals, Inc Main Business
Table 62. Regeneron Pharmaceuticals, Inc Latest Developments
Table 63. AbbVie Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors
Table 64. AbbVie Inc Retinal Biologics Product Offered
Table 65. AbbVie Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. AbbVie Inc Main Business
Table 67. AbbVie Inc Latest Developments
Table 68. Johnson & Johnson Services, Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors
Table 69. Johnson & Johnson Services, Inc Retinal Biologics Product Offered
Table 70. Johnson & Johnson Services, Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Johnson & Johnson Services, Inc Main Business
Table 72. Johnson & Johnson Services, Inc Latest Developments
Table 73. Amgen Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors
Table 74. Amgen Inc Retinal Biologics Product Offered
Table 75. Amgen Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Amgen Inc Main Business
Table 77. Amgen Inc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Retinal Biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Retinal Biologics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Retinal Biologics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Retinal Biologics Sales Market Share by Country/Region (2024)
Figure 8. Retinal Biologics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Retinal Biologics Market Size Market Share by Type in 2024
Figure 10. Retinal Biologics in Hospitals
Figure 11. Global Retinal Biologics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Retinal Biologics in Clinics
Figure 13. Global Retinal Biologics Market: Clinics (2020-2025) & ($ millions)
Figure 14. Retinal Biologics in Others
Figure 15. Global Retinal Biologics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Retinal Biologics Market Size Market Share by Application in 2024
Figure 17. Global Retinal Biologics Revenue Market Share by Player in 2024
Figure 18. Global Retinal Biologics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Retinal Biologics Market Size 2020-2025 ($ millions)
Figure 20. APAC Retinal Biologics Market Size 2020-2025 ($ millions)
Figure 21. Europe Retinal Biologics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Retinal Biologics Market Size 2020-2025 ($ millions)
Figure 23. Americas Retinal Biologics Value Market Share by Country in 2024
Figure 24. United States Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Retinal Biologics Market Size Market Share by Region in 2024
Figure 29. APAC Retinal Biologics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Retinal Biologics Market Size Market Share by Application (2020-2025)
Figure 31. China Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Retinal Biologics Market Size Market Share by Country in 2024
Figure 38. Europe Retinal Biologics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Retinal Biologics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Retinal Biologics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Retinal Biologics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Retinal Biologics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Retinal Biologics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 54. APAC Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 55. Europe Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 57. United States Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 58. Canada Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 61. China Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 62. Japan Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 63. Korea Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 65. India Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 66. Australia Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 67. Germany Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 68. France Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 69. UK Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 70. Italy Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 71. Russia Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 74. Israel Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Retinal Biologics Market Size 2026-2031 ($ millions)
Figure 76. Global Retinal Biologics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Retinal Biologics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Retinal Biologics Market Size 2026-2031 ($ millions)